We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
PEN

Price
256.87
Stock movement down
-0.14 (-0.05%)
Company name
Penumbra Inc
Exchange
(NYSE
,
Currency
USD
)
Sector
Healthcare >
Medical Devices
Markedsværdi
9.86B
Ent værdi
9.95B
Pris/omsætning
8.47
Pris/bog
8.93
Udbytte afkast
-
Udbyttevækst
-
Vekst år
-
FCF-udbetaling
-
Efterfølgende P/E
285.36
Fremtidig P/E
67.54
PEG
-
EPS-vekst
66.20%
1 års afkast
37.13%
3 års afkast
29.25%
5 års afkast
8.29%
10 års afkast
-
Senest opdateret: 2025-06-22

UDBYTTE

PEN betaler ikke udbytte

iO Charts is a Seeking Alpha partner

VÆRDIANSÆTTELSE

Værdiansættelsesforhold

Loading...
Værdiansættelsesforhold-data
Efterfølgende P/E285.36
Pris til OCF64.17
Pris til FCF73.47
Pris til EBITDA383.75
EV i forhold til EBITDA387.42

Værdiansættelse (salg/bogført værdi)

Loading...
Værdiansættelse (salg/bogført værdi)-data
Pris til omsætning8.47
Pris til egenkapital8.93
EV i forhold til salg8.55

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

ØKONOMI

Pr. aktie

Loading...
Data pr. aktie
Aktuelt antal aktier38.38M
EPS (TTM)0.88
FCF pr. aktie (TTM)3.42

Resultatopgørelse

Loading...
Resultatopgørelse-data
Omsætning (TTM)1.16B
Bruttofortjeneste (TTM)726.29M
Driftsindkomst (TTM)78.48M
Nettoindkomst (TTM)34.55M
EPS (TTM)0.88
EPS (1 år frem)3.80

Marginer

Loading...
Marginer-data
Bruttomargin (TTM)62.41%
Driftsmargin (TTM)6.74%
Fortjenstmargin (TTM)2.97%

Balance

Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Balancedata
Kontanter280.48M
Nettotilgodehavender176.05M
Omsætningsaktiver i alt891.75M
Goodwill166.35M
Immaterielle aktiver6.92M
Ejendomme, anlæg og udstyr341.67M
Sum aktiver1.48B
Kreditor33.15M
Kortfristet/nuværende langsigtet gæld226.69M
Summen af kortfristede forpligtelser153.19M
Sum gæld374.84M
Aktionærernes egenkapital1.10B
Materielle nettoaktiver0.00

Likviditet

Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Kontantstrøm-data
Likviditet fra driften (TTM)153.63M
Investeringsudgifter (TTM)19.46M
Fri pengestrøm (TTM)134.18M
Udbetalt udbytte (TTM)0.00

Finansiel indkomst

Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Data om finansiel indkomst
Egenkapitalafkast3.13%
Afkast af aktiver2.34%
Afkast af investeret kapital3.05%
Kontant afkast af investeret kapital11.84%

INFORMATION OM AKTIER

Aktiediagram

Loading...
Aktiekurs-data
Åbning258.18
Daglig høj260.10
Daglig lav256.12
Daglig volumen859K
Højeste gennem alle tider344.06
1 års analytiker estimat253.14
Beta0.51
EPS (TTM)0.88
Udbytte pr. aktie-
Ex-div dato-
Næste dato for resultatpræsentation-

Nedsidepotensial

Loading...
Nedsidepotensial-data
PENS&P500
Nuværende prisfald fra top notering-25.34%-3.04%
Højeste prisfald-62.66%-56.47%
Højeste efterår dato16 Jun 20229 Mar 2009
Gennemsnitlig fald fra toppen-17.73%-11.04%
Gennemsnitlig tid til nyt højdepunkt19 days12 days
Maks. tid til nyt højdepunkt511 days1805 days

iO Charts is a Seeking Alpha partner

OPLYSNINGER OM VIRKSOMHEDEN
PEN (Penumbra Inc) company logo
Markedsværdi
9.86B
Markedsværdi kategori
Mid-cap
Beskrivelse
Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.
Personale
4200
Investor relationer
-
SEC-indsendelser
Adm. direktør
Adam Elsesser
Land
USA
By
Alameda
Aktietype
Common stock
CCC-status
-
Utbyttefrekvens
-
ARRANGEMENTER OG PRÆSENTATIONER
ArrangementerPræsentationer
Loading...

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

FORSTÅ FORRETNINGEN
Loading...